CI
ALXN

Constellation Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Constellation Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.52M Buy
10,900
+325
+3% +$47.7K 0.28% 75
2015
Q4 		$2.02M Buy
10,575
+25
+0.2% +$4.37K 0.38% 61
2015
Q3 		$1.65M Buy
10,550
+775
+8% +$141K 0.34% 67
2015
Q2 		$1.77M Buy
9,775
+450
+5% +$77.7K 0.34% 69
2015
Q1 		$1.62M Buy
9,325
+475
+5% +$86K 0.31% 73
2014
Q4 		$1.64M Buy
8,850
+325
+4% +$60.2K 0.33% 66
2014
Q3 		$1.41M Sell
8,525
-25
-0.3% -$4.11K 0.31% 72
2014
Q2 		$1.34M Sell
8,550
-50
-0.6% -$7.89K 0.31% 72
2014
Q1 		$1.31M Buy
8,600
+475
+6% +$75.5K 0.32% 72
2013
Q4 		$1.08M Buy
8,125
+600
+8% +$72K 0.27% 81
2013
Q3 		$874K Buy
7,525
+475
+7% +$52.1K 0.27% 87
2013
Q2 		$650K Buy
+7,050
New +$679K 0.23% 99

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return